Welcome to KBC Securities

We believe banking is a craft, not an art or a science. As the integrated Equity House of KBC Group, we combine specialist expertise, skill and personal commitment to bring lasting value to our clients and people.

More about us


Our services

Collapse research area

Latest research

Benelux Morning Note22 aug 2017

Lotus Bakeries: Removed some biscuits out of stores after fipronil Tessenderlo: Preview 2Q/1H results VGP: The best is yet to come

Benelux Morning Note21 aug 2017

Lotus Bakeries: 1H17, the first half of a year of consolidation Picanol: 1H17 preview, we expect strong 1H17 results Roularta: First look 1H17 results

Benelux Morning Note18 aug 2017

Aedifica : Major expansion: Multiplying German assets by two Agfa : Rawmats, FX and Healthcare hardcopy pencilled in Boskalis : Feedback analyst meeting Brunel International : Q2 and FY17 guidance very weak Kiadis : Kreos ...

Benelux Company Note: Mithra18 aug 2017

Mithra is a clinical-stage company with a pipeline focused on novel native estrogen estetrol (E4)-based products and complex therapeutics for women’s healthcare. • The major changes to our investment case are based on upda ...

Benelux Morning Note17 aug 2017

ASIT biotech : Follow-up on hdmASIT+ to assess long term effect Boskalis H1: Dredging saves the day ForFarmers : 2H17 results growth will be lower than in 1H17 NN Group : Strong beat on capital, earnings in-line Sipef : S ...

Benelux Morning Note16 aug 2017

Boskalis: Buying an offshore survey company for £ 40m Heijmans: Moving in the right direction but not there yet Roularta: 1H17E – Traditional ad media in hot water Thrombogenics: Two posters on Ocriplasmin at the ASRS ...

Benelux Morning Note15 aug 2017

Brunel International: Preview 2Q17E TKH Group: Poor Q2 and guidance on growth investments

Benelux Morning Note14 aug 2017

NN Group : Solid Q2 expected. All eyes on Delta Lloyd Sipef : Preview 1H17